Illumina Financial Statements
Illumina Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Illumina Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 366.8 | 184.6 | 73.5 |
| Gross Profit ($ mil.) | 234.4 | 125.2 | 50.3 |
| Operating Income ($ mil.) | (301.2) | 37.8 | (21.5) |
| Total Net Income ($ mil.) | (278.4) | 40.0 | (20.9) |
| Diluted EPS (Net Income) | (5.14) | 0.82 | (0.52) |
Illumina Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 140.2 | 121.9 | 112.6 |
| Gross Profit ($ mil.) | 89.7 | 75.8 | 72.5 |
| Operating Income ($ mil.) | 23.9 | 19.0 | (32.8) |
| Total Net Income ($ mil.) | 15.4 | 13.4 | (4.1) |
| Diluted EPS (Net Income) | 0.23 | 0.21 | (0.05) |
Illumina Stock Quote & Chart
10/10/08 15:00:14 EST •
NASDAQ •
27.98
•
 -1.0200
•
-3.5172 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Illumina Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 9.95 | 2.03 | 1.48 |
| Price/Earnings Ratio | 108.17 | 21.44 | 15.28 |
| Price/Book Ratio | 9.56 | 2.05 | 1.45 |
| Price/Cash Flow Ratio | -- | 15.43 | 9.29 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Illumina Financial Ratios
Illumina Competitive Intelligence
| Affymetrix | Applied Biosystems | Luminex | |
|---|---|---|---|
| Annual Sales ($ mil.) | 371.3 | 2,093.5 | 75.0 |
| Employees | 1,141 | 5,000 | -- |
| Market Cap ($ mil.) | 574.6 | -- | 1,046.7 |
Competitive Landscape
